Increasing evidence implicates EVs in Alzheimer's disease (AD) pathogenesis through the propagation of amyloid-β, tau, and neuroinflammatory signals across neural and glial networks. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.